Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8786665 | European Journal of Surgical Oncology (EJSO) | 2018 | 36 Pages |
Abstract
Despite the high heterogeneity among studies, the data demonstrated that AR had comparable perioperative morbidity and mortality versus NAR. AR seemed to offer an advantage versus NAR in terms of DFS and OS among patients undergoing resection of HCC - especially among patients without cirrhosis. Thus, AR should be considered the preferred surgical option for patients with HCC when feasible.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Dimitrios Moris, Diamantis I. Tsilimigras, Ioannis D. Kostakis, Ioannis Ntanasis-Stathopoulos, Kevin N. Shah, Evangelos Felekouras, Timothy M. Pawlik,